These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7863828)

  • 21. Effect of platelet-activating factor receptor expression on CHO cell motility.
    Boccellino M; Biancone L; Cantaluppi V; Ye RD; Camussi G
    J Cell Physiol; 2000 May; 183(2):254-64. PubMed ID: 10737901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts.
    Alam AS; Moonga BS; Bevis PJ; Huang CL; Zaidi M
    Exp Physiol; 1993 Mar; 78(2):183-96. PubMed ID: 8385961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet activating factor increases intracellular calcium in isolated osteoclasts but does not modify bone resorption.
    Wucherpfennig AL; Dewhirst FE; Stashenko P
    Bone; 1993; 14(1):13-8. PubMed ID: 8442997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts.
    Kanehisa J
    Bone; 1989; 10(2):125-9. PubMed ID: 2765310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forskolin augments the effects of calcitonin on cytoplasmic spreading of isolated rat osteoclasts and plasma calcium levels in the rat.
    Nicholson GC; Yumita S; Moseley JM; Yates AJ; Martin TJ
    J Bone Miner Res; 1988 Apr; 3(2):181-4. PubMed ID: 3213613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro.
    Lerner UH; Ransjö M; Klaushofer K; Hörandner H; Hoffmann O; Czerwenka E; Koller K; Peterlik M
    Bone; 1989; 10(5):377-87. PubMed ID: 2605053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of human calcitonin on the cytoplasmic spreading of rat osteoclasts.
    Chambers TJ; Chambers JC; Symonds J; Darby JA
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1080-5. PubMed ID: 3760112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resorption of bone by isolated rabbit osteoclasts.
    Chambers TJ; Revell PA; Fuller K; Athanasou NA
    J Cell Sci; 1984 Mar; 66():383-99. PubMed ID: 6746762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin.
    Chambers TJ; Moore A
    J Clin Endocrinol Metab; 1983 Oct; 57(4):819-24. PubMed ID: 6193136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro.
    Pilkington MF; Sims SM; Dixon SJ
    J Bone Miner Res; 1998 Apr; 13(4):688-94. PubMed ID: 9556069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of calcitonin and colchicine on the cellular response to diphosphonate.
    Rowe DJ; Hausmann E
    Br J Exp Pathol; 1980 Jun; 61(3):303-9. PubMed ID: 7426385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin.
    Iida S; Kakudo S; Mori Y; Matsui M; Magota K; Kitajima Y; Nakamura N; Mano H; Hakeda Y; Azuma H; Kurokawa T; Kumegawa M
    Calcif Tissue Int; 1996 Aug; 59(2):100-4. PubMed ID: 8687977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body irradiation inhibits the escape phenomenon of osteoclasts in bones of calcitonin-treated rats.
    Nakamura T; Toyofuku F; Kanda S
    Calcif Tissue Int; 1985 Jan; 37(1):42-5. PubMed ID: 3922595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach for calcitonin determination based on target cell responsiveness.
    Zaidi M; Chambers TJ; Moonga BS; Oldoni T; Passarella E; Soncini R; MacIntyre I
    J Endocrinol Invest; 1990 Feb; 13(2):119-26. PubMed ID: 2329259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that protein kinase-A, calcium-calmodulin kinase and cytoskeletal proteins are involved in osteoclast retraction induced by calcitonin.
    Zheng MH; Wood DJ; Papadimitriou JM; Nicholson GC
    Exp Mol Pathol; 1992 Oct; 57(2):105-15. PubMed ID: 1426155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts.
    Donahue HJ; Iijima K; Goligorsky MS; Rubin CT; Rifkin BR
    J Bone Miner Res; 1992 Nov; 7(11):1313-8. PubMed ID: 1466256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoskeleton rearrangements during calcitonin-induced changes in osteoclast motility in vitro.
    Warshafsky B; Aubin JE; Heersche JN
    Bone; 1985; 6(3):179-85. PubMed ID: 4040768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calpain is required for normal osteoclast function and is down-regulated by calcitonin.
    Marzia M; Chiusaroli R; Neff L; Kim NY; Chishti AH; Baron R; Horne WC
    J Biol Chem; 2006 Apr; 281(14):9745-54. PubMed ID: 16461769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts.
    Datta HK; MacIntyre I; Zaidi M
    Biosci Rep; 1989 Dec; 9(6):747-51. PubMed ID: 2692724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.